MSB 4.26% $1.41 mesoblast limited

Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-381

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,189 Posts.
    lightbulb Created with Sketch. 1326
    Any day now, the FDA will be given Mesoblast approval.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.41
Change
0.058(4.26%)
Mkt cap ! $1.541B
Open High Low Value Volume
$1.37 $1.41 $1.37 $4.771M 3.425M

Buyers (Bids)

No. Vol. Price($)
2 2448 $1.41
 

Sellers (Offers)

Price($) Vol. No.
$1.41 335365 19
View Market Depth
Last trade - 10.43am 04/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.